Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Advancements in sequencing technologies
3.2.1.2 Increasing applications of genomics
3.2.1.3 Rising demand in clinical diagnostics
3.2.1.4 Rise in personalized medicine
3.2.2 Industry pitfalls & challenges
3.2.2.1 Regulatory and ethical concerns
3.2.2.2 Availability of alternative technologies
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Kits
5.2.1 DNA library preparation
5.2.2 RNA library preparation
5.2.3 Purification & quality control
5.2.4 Library quantification
5.2.5 Target enrichment
5.2.6 Other kit types
5.3 Reagents
5.4 Accessories
Chapter 6 Market Estimates and Forecast, By Platform, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 1st generation sequencing consumables
6.3 2nd generation sequencing consumables
6.4 3rd generation sequencing consumables
Chapter 7 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Clinical
7.2.1 Cancer diagnostics
7.2.2 Infectious disease diagnostics
7.2.3 Reproductive health
7.2.4 Other clinical applications
7.3 Forensic diagnostics
7.4 Pharmacogenomics
7.5 Agrigenomics
7.6 Other applications
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical and biotechnology companies
8.3 Hospitals and laboratories
8.4 Academic research institutes
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Agilent Technologies, Inc.
10.2 Bio-Rad Laboratories, Inc.
10.3 Danaher Corporation
10.4 F. Hoffmann-La Roche Ltd.
10.5 Illumina, Inc.
10.6 New England Biolabs
10.7 PerkinElmer, Inc.
10.8 Qiagen N.V.
10.9 Takara Bio Inc.
10.10 Thermo Fisher Scientific, Inc.
